Our Impact

The Rivkin Center works tirelessly towards a world where women live longer, healthier lives because cancers are prevented, caught early, or cured.

optimization-rocket-growthCreated with Sketch.

Research

Investing in cutting-edge research to prevent, detect, and treat ovarian cancer, a deadly and underfunded disease.

Over $13 Million
to ovarian cancer researchers since 1999
213 Research Grants Funded
in areas of Prevention, Early Detection, Treatment, Survivorship
Largest Applicant Pool
186 scientists in 2018 (up from 145 in 2017)
8.5x Return on Investment
Rivkin Funded scientists receive 8.5x in new funding from other institutions after Rivkin’s initial investment.

Our current funding rate is 8%, meaning we are leaving important science on the table. We want to see funding rates increase to 15% in two years.

people-woman-graduateCreated with Sketch.

Education

Educating and empowering women to prevent and detect ovarian and breast cancer as early as possible.
Educated over 25k women
at 683 educational parties in 6 states
40% of programming
to underserved & high-risk communities:
Low Income, Minority, LGBTQ+, Ashkenazi Jewish Heritage
Represented at all Pac-12 schools
95% of attendants
are likely or very likely to discuss health history with their family after attending party.
55

People assessed their risk for ovarian and breast cancer on Rivkin website in 2018. That’s up from 55 in 2017.

Group 15Created with Sketch.

Community

Fostering an ever-growing community of survivors, patients, researchers, clinicians, and advocates.

32% increase in attendees
at Ovarian Cancer Research Symposium
(over 250 attendees)
2,000 SummeRun Participants
at the 2018 SummeRun, plus a record number of survivors (89)
33 survivor-facilitators
up from 25 in 2016, we have 33 ovarian & breast cancer survivor-facilitators in the education programs.
For more details and information on the work of the Rivkin Center in 2018